Interactions of smoking with rs833061 polymorphism on the risk of non‐alcoholic fat liver disease in hubei han population: A preliminary case–control study

Iranian Journal of Basic Medical Sciences

Volumn 18, Issue 11, 2015, Pages 1112-1117

  Wu, Pengbo ^a   Hua, Yonglong ^b   Tan, Shiyun ^a   Li, Ming ^a   Yongxiang, Shu ^a   Fang, Guo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Department of Gastroenterology   (China)

Author keywords

Interactions; NAFLD; Polymorphisms; Smoking; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAN CHINESE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

EID: 84949225608     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mendez-Sanchez N, Arrese M, Zamora-Valdes D, Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 2007; 27:423-433.
2. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007; 13:6419-6424.
3. Macut D, Bjekic-Macut J, Savic-Radojevic A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res 2013; 40:51-63.
4. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 2004; 89:2640-2646.
5. Zhang C, Guo L, Guo X. [Interaction of polymorphisms of Leptin receptor gene Gln223Arg, MnSOD9Ala/Val genes and smoking in nonalcoholic fatty liver disease]. Wei Sheng Yan Jiu 2014; 43:724-731. (China)
6. Yang Z, Wen J, Li Q, Tao X, Ye Z, He M, et al. PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. Mol Cell Endocrinol 2012; 348:255-259.
7. Oniki K, Hori M, Saruwatari J, Morita K, Kajiwara A, Sakata M, et al. Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. Toxicol lett 2013; 220:143-149.
8. Elias I, Franckhauser S, Bosch F. New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance. Adipocyte 2013; 2:109-112.
9. Sun K, Wernstedt Asterholm I, Kusminski CM, Bueno AC, Wang ZV, Pollard JW, et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci USA 2012; 109:5874-5879.
10. Murray CJ, Roth G. Progress and challenges in the fight against smoking and cardiovascular disease. Eur Heart J 2014; 35:1625-1627.
11. Liu Y, Dai M, Bi Y, Xu M, Xu Y, Li M, et al. Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China. J Epidemiol 2013; 23:115-121.
12. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Chin J Hepatol 2003; 11:71. (China)
13. Jiang LL, Li L, Hong XF, Li YM, Zhang BL. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels. Eur J Gastroenterol Hepatol 2009; 21:662-666.
14. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 2007; 80:1125-1137.
15. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20:575-579.
16. Belo VA, Souza-Costa DC, Luizon MR, Izidoro-Toledo TC, Lanna CM, Pinheiro LC, et al. Vascular endothelial growth factor haplotypes associated with childhood obesity. DNA Cell Biol 2011; 30:709-714.
17. Moradzadegan A, Vaisi-Raygani A, Nikzamir A, Rahimi Z. Angiotensin converting enzyme insertion/-deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; rs2010963) in type II diabetic patients: Association with the risk of coronary artery disease. J Renin Angiotensin Aldosterone Syst 2014; 16:672-680.
18. Guruvaiah P, Govatati S, Reddy TV, Lomada D, Deenadayal M, Shivaji S, et al. The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women. J Assist Reprod Genet 2014; 31:1383-1389.
19. Sivaprasad S, Govardhan B, Harithakrishna R, Venkat Rao G, Pradeep R, Kunal B, et al. Association of vascular endothelial growth factor (VEGF) gene polymorphism and increased serum VEGF concentration with pancreatic adenocarcinoma. Pancreatology 2013; 13:267-272.
20. Kim HW, Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, et al. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Nephrology (Carlton) 2009; 14:681-688.
21. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008; 87:801-809.
22. Zhang LW, Li JP, Duan FF, Liu ZK, Zhan SY, Hu YH, et al. Interaction of type 2 diabetes mellitus with chromosome 9p21 rs10757274 polymorphism on the risk of myocardial infarction: a case-control study in Chinese population. BMC Cardiovasc Disord 2014; 14:170.
23. Fesinmeyer MD, North KE, Lim U, Buzkova P, Crawford DC, Haessler J, et al. Effects of smoking on the genetic risk of obesity: the population architecture using genomics and epidemiology study. BMC Med Genet 2013; 14:6.
24. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008; 28:386-395.